
IRadimed: Revise To Buy With Exceptional Incremental ROIC In Q4 (NASDAQ:IRMD)
zlikovec Investment summary After paring back the rating on IRadimed Corporation (NASDAQ:IRMD) late last year the company came in with a strong set of Q4 and full-year numbers. We emphasized the impact of potential downside […]